Renoprotective role of the vitamin D receptor in diabetic nephropathy
- Z. Zhang,
- L. Sun,
- ,
- G. Ning,
- A. W. Minto,
- J. Kong
- The University of Chicago,
- Pennsylvania State University
Open access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
1,25-Dihydroxyvitamin D3 negatively regulates the renin-angiotensin system (RAS), which plays a critical role in the development of diabetic nephropathy. We tested if mice lacking the vitamin D receptor (VDR) are more susceptible to hyperglycemia-induced renal injury. Diabetic VDR knockout mice developed more severe albuminuria and glomerulosclerosis due to increased glomerular basement membrane thickening and podocyte effacement. More fibronectin (FN) and less nephrin were expressed in the VDR knockout mice compared to diabetic wild-type mice. In receptor knockout mice, increased renin, angiotensinogen, transforming growth factor-β (TGF-β), and connective tissue growth factor accompanied the more severe renal injury. 1,25-Dihydroxyvitmain D3 inhibited high glucose (HG)-induced FN production in cultured mesangial cells and increased nephrin expression in cultured podocytes. 1,25-Dihydroxyvitmain D3 also suppressed HG-induced activation of the RAS and TGF-β in mesangial and juxtaglomerular cells. Our study suggests that receptor-mediated vitamin D actions are renoprotective in diabetic nephropathy.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 163-171 (9 pages)Journal (Volume, Issue Number)
Kidney International (Volume 73, Issue 2)Publication milestones
- Published - 01/10/2008
Publication status
ISSN
0085-2538Publication IDs
- Scopus: 37549046405
- PubMed: 17928826
